In a recent study, we performed targeted gene expression profiling of ACC tumour samples and identified up-regulated genes and pathways, including cyclin-dependent kinase (CDK) and polo-like kinase (PLK) families (9), whose inhibition may represent promising treatment options. Here, PLK1 is linked to neoplasm.